Investment
Features
FeesSafety
Academy
More
Pluang+

Compare Boston Scientific Corporation (BSX) vs EHang Holdings Ltd - ADR (EH) Price & Performance

Boston Scientific CorporationTrade
EHang Holdings Ltd - ADRTrade

Price performance (Past 24H)

Key statistics

Boston Scientific Corporation vs EHang Holdings Ltd - ADR — how do they compare? Boston Scientific Corporation trades at $42.62 (market cap $66.37B), while EHang Holdings Ltd - ADR trades at $5.49 (market cap $413.36M). The key difference: Boston Scientific Corporation is far larger — about 160.6× EHang Holdings Ltd - ADR's market cap. Which is the better fit depends on your goals.

BSXEH
Market Cap
$66.37B$413.36M
Sector
HealthIndustrials
52-Week High
$108.14$19.99
52-Week Low
$42.63$5.41
Enterprise Value
$75.94B$353.02M

Aura AI Summary

Signals from Pluang's Aura AI — not financial advice

Boston Scientific Corporation

Boston Scientific (BSX) trades at $44.65, down 0.27% with bearish technical signals despite strong fundamentals. The company delivered three consecutive earnings beats with Q3-Q1 2026 EPS exceeding expectations, while revenue grew to $20.07B in 2025 with improving profit margins. Technical indicators show bearish momentum with support at $44 and resistance at $45, though Wall Street maintains 88% buy rating with $70.20 consensus target.

BSX presents a compelling value opportunity with attractive valuation multiples (P/E 18.68, P/S 3.24) and robust financial health, though near-term headwinds include competitive pressures in key segments and recent stock price decline of nearly 60% from 2025 highs. The strong analyst consensus suggests significant upside potential if execution improves.

EHang Holdings Ltd - ADR

EHang Holdings (EH) trades at $5.41, down 3.22% on the day, reflecting ongoing volatility in the advanced air mobility sector. The stock shows a bearish technical trend with oversold RSI signals, while fundamentals reveal persistent losses with a net margin of -77.56% in 2025 despite a gross margin of 61.53%. Recent Q1 2026 earnings beat expectations but highlighted a sharp quarterly revenue drop, underscoring execution challenges amid expansion efforts.

The outlook remains high-risk with mixed analyst sentiment; a $6.97 consensus target suggests modest upside, but deep losses and cash burn necessitate careful monitoring of commercialization progress. Key risks include operational scalability, regulatory hurdles, and intense competition in the emerging eVTOL market.

Returns comparison

Trailing returns across standard periods

About Boston Scientific Corporation

Boston Scientific produces less invasive medical devices that are inserted into the human body through small openings or cuts. It manufactures products for use in angioplasty, blood clot filtration, cardiac rhythm management, catheter-directed ultrasound imaging, structural heart disease, upper gastrointestinal tract diagnostics, interventional oncology, and treatment of incontinence. The firm markets its devices to healthcare professionals and institutions globally. Foreign sales account for nearly half of the firm's total sales.

Read more on BSX

About EHang Holdings Ltd - ADR

EHang Holdings Ltd is an autonomous aerial vehicle (AAV) technology platform company. It focuses on making safe, autonomous and eco-friendly air mobility accessible to everyone. EHang provides customers in various industries with AAV products and commercial solutions: air mobility (including passenger transportation and logistics), smart city management and aerial media solutions. As the forerunner of cutting-edge AAV technologies and commercial solutions in the global Urban Air Mobility industry, it continues to explore the boundaries of the sky to make flying technologies benefit life in smart cities.

Read more on EH